Other
Mineral trioxide aggregate (MTA)
Mineral trioxide aggregate (MTA) is an intervention with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
17%
Ph phase_4
1
17%
Ph phase_3
1
17%
Ph not_applicable
3
50%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)
Trials by Status
unknown117%
completed350%
recruiting117%
active_not_recruiting117%
Recent Activity
2 active trials
Showing 5 of 6
active_not_recruitingnot_applicable
Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
NCT05811403
recruitingphase_4
Clinical and Radiographic Success of MTA vs Biodentine
NCT04863222
completednot_applicable
Pulpotomy Materials in Primary Molars
NCT07120321
completednot_applicable
Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material
NCT06402032
completedphase_3
Direct Pulp Capping in Primary Molars
NCT05530954
Clinical Trials (6)
Showing 6 of 6 trials
NCT05811403Not Applicable
Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
NCT04863222Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
NCT07120321Not Applicable
Pulpotomy Materials in Primary Molars
NCT06402032Not Applicable
Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material
NCT05530954Phase 3
Direct Pulp Capping in Primary Molars
NCT00228280Phase 1
Periapical Bone Healing After Apicectomy With and Without Retrograde Root Filling
All 6 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 6